ALS: Klinische Studien
Schon mal daran gedacht, an einer klinischen Studie teilzunehmen und so der medizinischen Forschung zu fördern?
Was Sie über die Teilnahme an einer klinischen Studie wissen sollten? - Klicken Sie hier
Der Nutzen von Teilnahme an klinischen Studien - Klicken Sie hier
| PRODUCT | STUDIE | STATUS | END DATE | RESPONSIBLE FIRM, UNIV, CLINIC OR COUNTRY |
| AMX-0035 | PHOENIX | Active Not Recruiting | 03/2024 | Amylyx |
|
Antiretroviral |
X | Recruiting | 02/2023 | NINDS, Australia |
|
Autologe Stamcellen |
X | Recruiting | US, Korea | |
|
Allogene Stamcellen |
X | Caribbean, universities | ||
| AP101-02 | Recruiting | 01/2025 | AL-S Pharma | |
| BIIB105 | ALSpire | Recruiting | 07/2026 | Biogen/Ionis |
| Cannabinoids | EMERALD | Active Not Recruiting | 01/2024 | Australia |
| CU(II)ATSM | Active Not Recruiting | 12/2022 | Coll Med Dev Australia | |
| Dazucorilant | DAZALS | Recruiting | 06/2024 | Corcept Therapeutics |
| Deferiprone | FAIR-ALS II | Recruiting | 04/2022 | France |
| Edaravone oral, FAB122 | ADORE | Active Not Recruiting | 06/2024 | Mitsubishi, Ferrer |
| Fasudil | ROCK REAL | Active Not Recruiting | 11/2023 | Germany, France, US |
| GDNF | Recruiting | 09/2023 | Cedars Sinai | |
| Healey Platform Trial | HEALEY | Recruiting | NEALS | |
| Ibudilast (MN-166) | COMBAT-ALS | Recruiting | 12/2024 | MediciNova |
| ION363 fus | FUSION | Recruiting | 03/2024 | Ionis |
| Lithium Magnet | MAGNET | Recruiting | Tricals | |
| Masinitib | Recruiting | 12/2023 | AB Science | |
| Memantine and Trazodone | SMART | Recruiting | 12/2026 | UK |
| Presymptomatic sod1 | ATLAS | Recruiting | 08/2027 ... |
Biogen |
|
Q-cells |
ALTA BOLT | Not Yet Recruiting | 12/2024 | Q Therapeutics |
| Rapamycin | MONEPANTEL | Active Not Recruiting | 05/2023 | Univ Modena |
| RNS60 | Not Yet Recruiting | 06/2024 | Italy and US | |
| SAR443820 | HIMALAYA | Active Not Recruiting | 04/2024 | Sanofi |
| BIIB067 Long Term sod1 | Active Not Recruiting | 06/2024 | Biogen/Ionis | |
| TPN-101 C9 | Transposon | Recruiting | 03/2025 | Transposon |
| TUDCA | TUDCA-ALS OLE | Active Not Recruiting | 12/2022 | horizon 2020 |
